Saturday, October 12, 2013

NDSU discovery could reduce E. coli's power to make us sick

This article is very exciting because the bacterium that is responsible for Lyme disease (borrelia burgdorferi) can, once it is established in the body, disguise itself and render itself almost intractable by sheathing itself in 'biofilms'. The research reported here, developed using another bacterium, E. coli, could be applicable to other bacteria, such as borrelia burgdorferi, preventing its colonies from forming and hiding within biofilms.  This would make eradication of Bb much easier, and possibly more permanent  - Bob

by Dan Gunderson, Minnesota Public Radio
October 10, 2013

 FARGO, N.D. — Researchers at North Dakota State University have discovered a way to make the E. coli bacteria less dangerous to human health, a finding that could improve safety in food and medical devices.

Bacteria can make people sick, and the organisms are much more dangerous when they form a social network called a biofilm that allows them to communicate and protect each other. According to the National Institutes of Health, biofilms cause 60 to 80 percent of microbial infections.

E. coli could soon become less of a threat thanks to the work of Meredith Irsfeld, a graduate student researcher at NDSU who fed bacteria a neurotransmitter found in the brain called phenylethylamine, or PEA. When the E. coli bacteria consumed PEA, they stopped growing the hair-like appendages called flagella they need to move and attach to surfaces and each other.

If bacteria can't form biofilm, they are less dangerous and more easily controlled with antibiotics.

The discovery represents a significant advancement because defeating biofilm would make it difficult for bacterial to link in ways that make them more potent and difficult to kill.

"They form on surfaces. They glue themselves to the surface, they glue themselves to each other and after that they are very difficult to remove," said Birgit Pruess, an associate professor in the Veterinary and Microbiological Sciences Department at NDSU.

"Antibiotics don't get to them," said Pruess, who has spent years looking for ways to defeat biofilm. "The immune system of the human host doesn't either."

PEA, which also is sold as a health food supplement alleged to enhance weight loss and fight depression, could be a key to fighting E. coli because it does not allow bacterial connections, Irsfeld said.

"The gene that produces flagella is brought down immensely," she said. "So it's not able to form that initial attachment. And that initial attachment is needed for biofilm to even begin."

A lot of researchers are now looking at ways to control bacteria by suppressing genes to change behavior but the NDSU lab is the first to try using PEA, Pruess said.

Because this approach changes the bacteria rather than killing them, it will take longer for the bacteria to adapt and become resistant, she said.

Pruess received a $358,750 NIH grant for the research. She also received funding from the North Dakota Beef Commission, and the State of North Dakota.

More studies are needed to fully understand why this specific gene is suppressed, but researchers are already moving forward on practical uses for what they've learned.

NDSU researchers will look for ways to embed PEA in medical devices to prevent biofilm formation.

Biofilms are a big problem for medical devices because they can form on hip or knee implants, pacemakers or catheters used in dialysis or cancer treatments. That can cause serious infections that resist antibiotic treatment.

Pruess said there are also many ideas to use the discovery to improve food safety.

"Someone said, 'Why don't you fit it in a little bottle and sell it in the store so people can use it in their own refrigerators?'" she said. "We just gave a seminar and someone said, 'Why don't you put it in the package material for the beef?' So there is right now a lot of ideas different people bring in about what one could do with this."

Pruess thinks a ready-to-use material could be developed in two or three years. Government approval might take much longer.

Because of the federal government shutdown, however, the next phase of research is on hold.


Source:
http://minnesota.publicradio.org/display/web/2013/10/10/ndsu-discovery-defeats-biofilm

Thursday, October 10, 2013

My Post to the Katie Couric show

At the end of the Catie Couric show yesterday afternoon (Oct 9, 2013), she invited anyone interested to 'keep the conversation going' by going to her site and telling our stories, etc. Here's what I sent in. So far I can't find it listed among the more than 1200 comments that are rolling in. Perhaps it was too long, so I'll post it here for anyone who's interested in reading it...

Dear Katie,

Thank you so much for covering this difficult topic on your show, and being so genteel yet also bringing both sides of the controversy together so adeptly.  You and your staff chose your guests well.

I want to share with you my story, and a few opinions after dealing with Lyme issues for a decade.

I grew up in eastern Pennsylvania, and often worked and played in the woods. Woods and deer surrounded our house. I worked as a surveyor's apprentice and for a tree surgeon as summer jobs. Thus, it was not uncommon to have ticks on me after a day's work. 

I am now 60 and live in California, where I have been since 1977. At ages 18, 30, and 50 I had major meltdowns. My symptoms were feelings of pressure in the neck and head, insomnia, depression, and anxiety, mostly. Age 50 was the worst. The other two events lasted 1-2 year, and eventually self-corrected.

But at age 50, I did not recover, and I was incredibly ill. My mind went haywire to the point where I had to go to psychotherapy every day for a month, at the outset, just to prevent me from committing suicide.

Alan MacDonald, MD writes to Katie Couric, after her Lyme show

Dear Katie,

Infections of the Borrelia complex are plural, chronic, and recalcitrant to short therapies in many patients. Lyme is an outmoded label for this plurality of public health issues and the word "Lyme" leads to oversimplification of regulatory thinking about pluralities of actual diseases in the human host.

These conceptual voids lead to under-diagnosis, under-treatment, and under-reporting of actual human disease cases. Morbidities from chronic borreliosis - complex diseases and mortalities are not properly diagnosed or recorded by the Centers for Disease Control.

Politicization of these medical entities has become codified and entrenched by
rules promulgated by the CDC and the Infectious Disease Society of America (IDSA). Proper diagnosis and proper treatment of borreliosis complex diseases must be individualize to manage each patient. Central Dogma was rethought and discarded in the early years of DNA science. The AIDS conundrum was only solved by rejection of the Central Dogma and the awakening to the idea that the AIDS virus and other Reverse Transcriptases produced disease by reversal of the Central Dogma of DNA. These were unimagined by the CDC.

Statisticians in Atlanta Georgia, and "rules" about Haitian diseases did not lead the way in the management of the worldwide AIDS crisis.

The exposee "And the Band Played On" lighted the way for a pathway to truth which had been steadfastly spurned by the CDC. Presently the CDC is spurning knowledge about the Borreliosis/Lyme epidemic. Doctors of philosophy prevail over doctors of medicine in the inner  workings of the Centers for Disease Control. Only doctors of medicine are obligated to solve individual patient health problems.

Let the doctors who actually take care of patients practice the healing art, without encumbrances by doctors of philosophy and statisticians.

Alan B. MacDonald, MD, FCAP October 9,2013

RESEARCHER BIO 
MD, American Board of Pathology Certified in both Anatomic Pathology and Clinical Pathology.
35 years of Hospital Diagnostic Pathology experience in all areas of Diagnostic Pathology
of Benign, Infection, and Malignant diseases of humans. 
30 Years of experience with Borrelia Research, at the level of Bench research in a biosafety Level 2 Microbiology, and experience with Ultracentrifugation, Pulsed Tangential Alternating Field Electrophoresis, Electron Microscopy, In vivo borrelia primary Isolation, borrelia focused Autopsies on Fetal and Human patients, Primary Isolation of borrelia from Frozen Alzheimer Brains obtained from Dr. George Glenner's UCSD Brain Bank, Primary Isolation of borrelia from Autopsy Alzheimer's Disease brain in community hospital practice, PCR study of the Flagellin B ORF of Borrelia burgdorferi, DNA sequence analysis of PCR products for FLAGELLIN B  DNA from AD frozen tissues from tbe Harvard Mclean Hospital Brain Tissue resource Center, Development and validation of Borrelia-specific DNA probes for Flagellin B, and for the inner cell membrane of Borrelia burgdorferi species BB0060., confirmation that biofilms of Borrelia exist IN VITRO, and extension to IN VIVO Borrelia biofilms in human bacterial Endocarditis, various Cutaneous borrelioses, and Neuroborreliosis.

Reactions to the Katie Couric show (video clips)


The Katie Couric television program about Lyme disease was well done. Dr Richard Horowitz put in a strong effort to counter IDSA denials of chronic Lyme. Even more impressive is the huge number of comments posted on Katie's website.  

You also can see clips from this show there:

Scroll down on that page, and you'll see the video clips and the comments (which go on for pages, and pages, and pages, and...

Wednesday, October 9, 2013

Chronic Lyme on Katie Couric, Oct 9





Dr. Horowitz talks Lyme with Katie Couric 

Watch top LLMD & Lyme survivor on Oct. 9 show

Dr. Richard Horowitz, one of the nation's leading Lyme-literate MDs, will discuss chronic Lyme on the Katie Couric show on Oct. 9. 

Horowitz has treated more than 12,000 chronic Lyme patients and is the author of the forthcoming book Why Can't I Get Better: Solving the Mystery of Lyme and Chronic Disease. He is joined on the show by Lyme survivor Kelly Downing. 


Horowitz also coming to San Diego Lymewalk

He'll join other speakers at Oct. 19 rally

Dr. Horowitz joins a line-up of speakers at the San Diego Lymewalk and Rally, on Oct. 19 (next door to ILADS medical conference.) 

Others include Lyme researcher Dr. Eva Sapi; The Lyme Policy Wonk, Lorraine Johnson; Lyme survivor/TV personality Brooke Landau, and more. 
Dr. Horowitz will also bring advance copies of his book. (Not available elsewhere until November.) Click for more info about this event.
LymeDisease.org, publisher of The Lyme Times, advocates nationally for people with tick-borne diseases, educates the public, and helps fund medical research. We are the go-to source for news, information, and health policy analysis in the Lyme community. Become a member today.

Like us on Facebook      Follow us on Twitter      Visit our blog

Email Marketing by
Constant Contact

Tuesday, October 8, 2013

Lyme Protest in San Francisco Last Weekend

Because of the IDSA annual conference being held in San Francisco last weekend, Oct 8, 2013. a demonstration/teach-in was held outside of the Moscone Conference Center in downtown San Francisco. It was sweltering hot out, which is something of a rarity in SF, but still pretty well attended. Several long-time Lyme patients spoke, including Jordan Fisher Smith and Barbara Arnold, Esq.  There was some media coverage, but not as much as we would have liked. However, out of the event several encouraging results emerged:


  •  The SF Chronicle is going to interview some local Lyme patients and cover the event in arrears. 
  • This email came in later today (the Tuesday after the event), from Kris Newby, coproducer of the very successful Oscar-nominated documentary film about Lyme disease, Under Our Skin
On Oct 8, 2013, at 2:02 PM, Kris Newby wrote:
I attended Dr. Wormer's IDSA session on TBDs on Saturday in SF, and at the end of his talk, the panel moderator said that the IDSA "was in the beginning stages of updating the IDSA Lyme guidelines."

No NIH or CDC attendees were present bc/ of the gov't shutdown.

The LymeDisease.org protest outside the meeting benefited from a power outage in the Moscone Center, which forced everyone at the conference onto the street so that they could see the protesters and the billboard truck, which urged ID physicians to treat chronic Lyme patients.

Kris Newby
Under Our Skin

I have to admit, I got a big kick out of that. 

Medical researchers report four deaths due to Lyme carditis

Written by
Roberto LoBianco
For the Poughkeepsie Journal

Four deaths have been reported in medical journals from a heart condition associated with Lyme disease called Lyme carditis. The condition is being investigated in the death of a 17-year-old Poughkeepsie High School honor student who died Aug. 5; evidence of Lyme disease was found in his blood, organs and heart.
The cases, drawn from references provided by the U.S. Centers for Disease Control and Prevention, include:
• A 37-year old man who died in 2008 the day after visiting a doctor. The man reported a month-long series of fevers, rash and other symptoms. According to a report published in the journal Cardiovascular Pathology, he had an irregular heartbeat and tested positive for Lyme disease the day before he died. An autopsy found that he also suffered from heart inflammation.
• A patient who died from cardiac arrest caused by Lyme myocarditis or heart inflammation. The patient, described in a 1993 report in the Journal of Neurology, was among patients with Lyme myositis, or muscle inflammation, between the ages of 37 and 70. They came down with symptoms, including muscle pain, tenderness, swelling and weakness.
• A 31 year-old male farm worker in Great Britain — the only geographical reference in the four articles — who tested positive for Lyme disease on his first screening. An autopsy found the man suffered from an enlarged heart and an irregular heart beat; he had no telltale Lyme disease rash before becoming ill, according to a 1990 article in the Postgraduate Medical Journal. The article recommended that doctors "be especially vigilant with young patients from rural areas presenting with heart block," a disturbance of the heart's rhythm.
• A 66-year old man who died of "cardiac involvement of Lyme disease." According to a 1985 report published in the Annals of Internal Medicine, he died 18 hours after being taken to the hospital with chills, muscle pain and other symptoms. Lyme spirochetes were found in the victim's heart tissue and an autopsy found that he had an inflamed heart.
Carditis occurs in 4 to 10 percent of cases of Lyme disease and usually begins three to six weeks after the initial illness, according a 2012 report published in the journal Clinical Medicine and Diagnostics.
In a statement, the CDC said it "recommends treatment, regardless of serologic [blood] test results, for patients suspected of having early stages of Lyme disease. This would include patients suspected of having Lyme carditis."
Read the story at the source:

http://www.poughkeepsiejournal.com/article/20131006/NEWS01/310060047/Medical-researchers-report-four-deaths-due-Lyme-carditis

Thursday, October 3, 2013

DEET & Molecular Reverse Engineering


Researchers said Wednesday they had discovered four natural mosquito repellents to succeed DEET, a compound whose origins go back to World War II.

DEET -- the abbreviation for N,N-diethyl-meta-toluamide -- was introduced by the US Army in 1946 after troops deployed in the Pacific theatre fell sick from malaria and other mosquito-borne diseases.

It remains the primary insect repellent in use today, but has many limitations. It has to be applied frequently and is expensive, which rules it out for combating disease in regions where malaria is endemic. It also dissolves types of plastic, synthetic fabrics and painted surfaces.

More worryingly, there is some evidence that flies and mosquitoes are developing resistance to it, and that the chemical disrupts an important enzyme in the mammalian nervous system called acetylcholinesterase.

In experiments that combined entomology and data-crunching computing, scientists at the University of California at Riverside uncovered four alternatives that may send DEET into retirement after 67 years.

"The candidates contain chemicals that do not dissolve plastic, are affordable and smell mildly like grapes, with three considered safe in human foods," says their study published Wednesday in the journal Nature. "Our findings pave the way to discover new generations of repellents that will help fight deadly insect-borne diseases worldwide."

The scientists' first step was to understand how mosquitoes sense DEET and become repelled by it. For this, they turned to a cousin of the mosquito called the fruit fly, or Drosophila melanogaster, one of the most closely-studied lab creatures of all.

The answer, they found, lies in a receptor called Ir40a, found in nerve-system cells in a pit-like structure in the fruit fly's antenna.

The next step was to look for an odor molecule that would fit and activate the receptor, rather like a key turns a lock. It also had to be a natural substance, found in fruits, plants or animals.

Screening exercise

The data pool proved to be a mini-ocean, comprising nearly half a million potential compounds.
This was whittled down to nearly 200. Of these, 10 compounds seemed the most promising and were put to the test on fruit flies.

Of the 10, eight turned out to be good repellents on fruit flies. Four of them were then tested on mosquitoes, all of which worked.

The good news is that out of the four, three have already been approved as food flavours or fragrances by the US Food and Drug Administration (FDA).

Called methyl N,N-dimethyl anthranilate, ethyl anthranilate and butyl anthranilate, they can be applied to bed nets, clothes and curtains to ward off insects, say the scientists.

The secret behind the breakthrough was to locate the Ir40a receptor and develop an algorithm to screen potential chemicals, said Anandasankar Ray, an associate professor of entomology. Ir40a, according to the probe, is highly conserved, a scientific term meaning that it shows little signs of evolutionary change.

That, too, is good news. One of the problems for drug designers is when they face a moving target -- a mutational shift in DNA that means the treatment becomes less effective. The receptor is also common across many flies and other insects that are a pest for humans and plants.

"Our findings could lead to a new generation of cheap, affordable repellents that could protect humans, animals and, in the future, our crops," said Ray.

Tuesday, October 1, 2013

Katie Couric Lyme Show


See update below....

Noted Lyme Dr. Richard Horowitz was interviewed on the Katie Couric show. Here's his report about what we believe will be the broadcast date for the show. Dr. Horowitz is a wonderful speaker, and a strong advocate for chronic Lyme patients.


Posts: 2454
Group Leader
I don't know how long of a segment she is doing, if Lyme gets the whole show, or what.  But Dr. Horowitz posted a letter:

Hi everyone, 
I just received news of the air date for the Katie Couric show that I was just filmed on. If you could send out the information to the Lyme groups and any interested contacts, would be appreciated. A follow-up email should be coming on how to go online and blog for the online debate that will be following the show. Everyone will have the opportunity to discuss their personal experience, and if and how they were affected by the IDSA guidelines. 
Thanks,
Dr H.

The show will run on October 9th. I don't know what time the Katie show is on.
Share with people!

Station finder: http://katiecouric.com/station-finder/

UPDATE,  Oct 8, 

This just in....


October 9th's edition of the television show Katie will feature the actor Daniel Radcliffe and a discussion on Lyme Disease with Dr. Richard Horowitz.

Details and a video promo can be found here.

Program promo text: "Are you at risk for Lyme Disease? Does Chronic Lyme Disease really exist? Find out what you need to know to protect your family."
To find out the time and channel for your exact location to watch the program, go here.

The role of small intestinal bacterial overgrowth in Parkinson's disease

This is the first study I have bumped into that draws a correlation between unhealthy gut ecology and Parkinson's disease. Considering the state of my gut due to ingestion of antibiotics for Lyme treatment over the years, I wouldn't be surprised if there is a cause and effect relationship between the two. One of my Lyme doctors just ordered a new stool sample for testing the health of my gut. This will use a different lab than the test I had done a month or so ago. The last one used DiagnosTechs. This time we are using Genova lab. I will report the results when I receive them. 

I left some links down below that are relevant as well. They were attached to the original abstract so I left them in. 

Authors


Fasano A, et al. 
Journal Mov Disord. 2013 Aug;28(9):1241-9. doi: 10.1002/mds.25522. Epub 2013 May 27.

Affiliation
Department of Neurology, Catholic University of Sacred Heart, Gemelli University Hospital, Rome, Italy; Department of Neuroscience, AFaR-Fatebenefratelli Hospital, Rome, Italy.

Abstract

Parkinson's disease is associated with gastrointestinal motility abnormalities favoring the occurrence of local infections. The aim of this study was to investigate whether small intestinal bacterial overgrowth contributes to the pathophysiology of motor fluctuations. Thirty-three patients and 30 controls underwent glucose, lactulose, and urea breath tests to detect small intestinal bacterial overgrowth and Helicobacter pylori infection. Patients also underwent ultrasonography to evaluate gastric emptying. The clinical status and plasma concentration of levodopa were assessed after an acute drug challenge with a standard dose of levodopa, and motor complications were assessed by Unified Parkinson's Disease Rating Scale-IV and by 1-week diaries of motor conditions. Patients with small intestinal bacterial overgrowth were treated with rifaximin and were clinically and instrumentally reevaluated 1 and 6 months later. The prevalence of small intestinal bacterial overgrowth was significantly higher in patients than in controls (54.5% vs. 20.0%; P = .01), whereas the prevalence of Helicobacter pylori infection was not (33.3% vs. 26.7%). Compared with patients without any infection, the prevalence of unpredictable fluctuations was significantly higher in patients with both infections (8.3% vs. 87.5%; P = .008). Gastric half-emptying time was significantly longer in patients than in healthy controls but did not differ in patients based on their infective status. Compared with patients without isolated small intestinal bacterial overgrowth, patients with isolated small intestinal bacterial overgrowth had longer off time daily and more episodes of delayed-on and no-on. The eradication of small intestinal bacterial overgrowth resulted in improvement in motor fluctuations without affecting the pharmacokinetics of levodopa. The relapse rate of small intestinal bacterial overgrowth at 6 months was 43%. © 2013 Movement Disorder Society.

Copyright © 2013 Movement Disorder Society.

PMID

 23712625 [PubMed - in process]

Related Citations

Show all